Research shows that combining GLP-1 medications with proper nutrition and exercise enhances weight loss, making the OPTAVIA ASCEND ... surprise of 553.1%, on average. You can see the complete ...

Medifast, Inc. MED has introduced a high-protein product line, OPTAVIA ASCEND, designed to support individuals using GLP-1 ...

It's similar to eating habits in Blue Zones where people live longer, healthier lives on average. The DASH diet is short ...

Medifast, Inc. MED has introduced a high-protein product line, OPTAVIA ASCEND, designed to support individuals using GLP-1 medications and those seeking help to maintain weight loss. The new line ...

Medifast, Inc. MED has introduced a high-protein product line, OPTAVIA ASCEND, designed to support individuals using GLP-1 medications and those seeking help to maintain weight loss. The new line ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Months after posting weight loss of 7.5% at 36 days for patients taking MET-097i, Metsera releases mid-stage results of just ...

many overlook that they are just one tool to support weight loss and are not intended to be used without lifestyle changes," said Dan Chard, Chairman and CEO of Medifast. "OPTAVIA ASCEND was ...